{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T03:55:42Z","timestamp":1773719742658,"version":"3.50.1"},"reference-count":42,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2465,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1111\/j.1365-2710.2008.00950.x","type":"journal-article","created":{"date-parts":[[2008,11,11]],"date-time":"2008-11-11T10:37:55Z","timestamp":1226399875000},"page":"591-601","source":"Crossref","is-referenced-by-count":20,"title":["Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice"],"prefix":"10.1155","volume":"33","author":[{"given":"N. S.","family":"Vermeer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. V.","family":"Bajorek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","reference":[{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB1","volume-title":"\u201cAustralia\u2019s health\u201d 2006","author":"Australian Institute of Health and Welfare","year":"2006"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB2","volume-title":"National health priority areas report: cardiovascular health 1998","author":"Commonwealth Department of Health\/Australian Institute of Health and Welfare","year":"2000"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB3","first-page":"S3","volume":"184","author":"Acute Coronary Syndrome Guidelines Working Group","year":"2006","journal-title":"MJA"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","article-title":"Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials","volume":"361","author":"Keeley","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1592\/phco.27.4.553","article-title":"Contemporary issues in clopidogrel therapy: new evidence shaping clinical practice","volume":"27","author":"Emmons","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB6","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB7","volume-title":"Percentage of patients with acute coronary syndrome that are prescribed appropriate medication at discharge (indicator 5.1)","author":"NSW Therapeutic Advisory Group","year":"2007"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB8","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1053\/euhj.2002.3385","article-title":"Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"23","author":"Bertrand","year":"2002","journal-title":"European Heart Journal"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0195-668X(02)00618-8","article-title":"Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology","volume":"24","author":"Van de Werf","year":"2003","journal-title":"European Heart Journal"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB10","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/01.CIR.0000134791.68010.FA","article-title":"ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction)","volume":"110","author":"Antman","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB11","first-page":"e148","article-title":"ACC\/AHA 2007 Guidelines for the management of patients with unstable angina\/non ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina\/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine","volume":"116","author":"Anderson","year":"2007","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB12","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1053\/euhj.2001.3081","article-title":"Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE)","volume":"23","author":"Fox","year":"2002","journal-title":"European Heart Journal"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB13","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/euhj.2001.2610","article-title":"Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme","volume":"22","author":"EUROASPIRE II Study Group","year":"2001","journal-title":"European Heart Journal"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1445-5994.2007.01435.x","article-title":"Current management of acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective audit","volume":"37","author":"Chew","year":"2007","journal-title":"Internal Medicine Journal"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/01.hjr.0000244573.10229.6e","article-title":"Use of secondary preventive medications after the first attack of acute coronary syndrome","volume":"14","author":"Salomaa","year":"2007","journal-title":"European Journal of Cardiovascular Prevention and Rehabilitation"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ahj.2003.06.004","article-title":"Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation","volume":"147","author":"Orford","year":"2004","journal-title":"American Heart Journal"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.296.1.72","article-title":"Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality","volume":"296","author":"Bradley","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.amjmed.2004.03.017","article-title":"Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States","volume":"117","author":"Ergin","year":"2004","journal-title":"The American Journal of Medicine"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB19","author":"Australian Medicines Handbook Pty Ltd","year":"2007"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB20","volume-title":"International statistical classification of diseases and related health problems, 10th revision. ICD-10 Online","author":"World Health Organisation","year":"2007"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB21","first-page":"U1678","article-title":"Use of evidence-based management for acute coronary syndrome","volume":"118","author":"Tang","year":"2005","journal-title":"The New Zealand Medical Journal"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-143-4-200508160-00005","article-title":"Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit","volume":"143","author":"Rothberg","year":"2005","journal-title":"Annals of Internal Medicine"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB23","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB25","doi-asserted-by":"crossref","first-page":"326","DOI":"10.18553\/jmcp.2007.13.4.326","article-title":"Pharmacoeconomic analysis of clopidogrel in secondary prevention of coronary artery disease","volume":"13","author":"Cheng","year":"2007","journal-title":"Journal of Managed Care Pharmacy"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB26","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"The New England Journal of Medicine"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB27","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation","volume":"352","author":"Sabatine","year":"2005","journal-title":"The New England Journal of Medicine"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB28","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1592\/phco.27.8.1145","article-title":"Antiplatelet therapy in patients with unstable angina and non-ST-segment-elevation myocardial infarction: findings from the CRUSADE national quality improvement initiative","volume":"27","author":"Bottorff","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB29","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","article-title":"Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study","volume":"369","author":"Daemen","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB30","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(04)17275-9","article-title":"Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy","volume":"364","author":"McFadden","year":"2004","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB31","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/jama.299.5.532","article-title":"Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome","volume":"299","author":"Ho","year":"2008","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB32","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacc.2006.10.026","article-title":"Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents","volume":"48","author":"Pfisterer","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.297.2.joc60179","article-title":"Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation","volume":"297","author":"Eisenstein","year":"2007","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB34","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jacc.2007.01.003","article-title":"Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians","volume":"49","author":"Grines","year":"2007","journal-title":"Journal of American College of Cardiology"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ahj.2007.04.031","article-title":"Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: insights from the Sibrafiban vs aspirin to yield maximum protection from ischemic heart events postacute coronary syndromes trials","volume":"154","author":"Wong","year":"2007","journal-title":"Am Heart J"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5694\/j.1326-5377.2005.tb06729.x","article-title":"Variations in indicated care of patients with acute coronary syndromes in Queensland hospitals","volume":"182","author":"Scott","year":"2005","journal-title":"The Medical Journal of Australia"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB37","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jacc.2005.05.084","article-title":"Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative","volume":"46","author":"Alexander","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB38","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1001\/archinte.165.14.1630","article-title":"Quality of care by classification of myocardial infarction: treatment patterns for ST-segment elevation vs non-ST-segment elevation myocardial infarction","volume":"165","author":"Roe","year":"2005","journal-title":"Archives of Internal Medicine"},{"issue":"Suppl 1","key":"10.1111\/j.1365-2710.2008.00950.x-BIB39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1538-7836.2007.02499.x","article-title":"Combined antiplatelet and anticoagulant therapy: clinical benefits and risks","volume":"5","author":"Eikelboom","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB40","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1161\/01.CIR.98.16.1597","article-title":"Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study","volume":"98","author":"Bertrand","year":"1998","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB41","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2710.2008.00950.x-BIB42","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1378\/chest.130.6.1823","article-title":"Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention","volume":"130","author":"Lip","year":"2006","journal-title":"CHEST"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2710.2008.00950.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2710.2008.00950.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T11:26:56Z","timestamp":1709378816000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2710.2008.00950.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2710.2008.00950.x","relation":{},"ISSN":["0269-4727","1365-2710"],"issn-type":[{"value":"0269-4727","type":"print"},{"value":"1365-2710","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}